Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.85−0.02 (-1.88%)
Close on Nov 19, 2026Market cap $6.86MP/E –Yield –
Immuron free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2026 it was -A$3.26M. The highest annual figure on record is -A$1.80M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -A$3.26M | – |
| FY2024 | Jun 30, 2024 | -A$5.88M | – |
| FY2023 | Jun 30, 2023 | -A$2.60M | – |
| FY2022 | Jun 30, 2022 | -A$3.16M | – |
| FY2021 | Jun 30, 2021 | -A$4.09M | – |
| FY2020 | Jun 30, 2020 | -A$3.15M | – |
| FY2019 | Jun 30, 2019 | -A$1.80M | – |
| FY2018 | Jun 30, 2018 | -A$3.51M | – |
| FY2017 | Jun 30, 2017 | -A$6.95M | – |
| FY2016 | Jun 30, 2016 | -A$5.16M | – |
See a number that looks wrong?